Back
Nutrison

Nutrison

Features
  • Suitable as a sole source of nutrition.^
  • Whey-dominant P4 protein blend: in line with international recommendations on protein quality/amino acid profile and for gastrointestinal tolerance benefits. 1-7
  • No added fibre: for patients requiring residue-restricted diets.
  • Fish oils: to provide Docosahexaenoic acid (DHA) and Eicosapentaenoic acid (EPA).
  • Medium chain triglycerides (MCT): for easier fat digestion and absorption.8-9
  • Enriched with carotenoids: in line with general health recommendations for their antioxidant properties and positive effect on immune function.10
  • 1000ml OpTri bottle: suitable for closed or open system feeding via ISO compliant flip-top screw cap.

Product Information

A nutritionally complete, fibre free, ready-to-use enteral tube feed.

Link copied!
Indications

For use in the dietary management of:

  • Disease-related malnutrition.
  • Patients requiring a residue-restricted diet.
Important Notice
  • Not for parenteral use.
  • Not suitable for patients with galactosaemia.
  • Not suitable for patients with cow’s milk protein allergy.
  • Not suitable for infants under 1 year of age.
  • Use with caution in children aged 1-6 years of age.
  • Use with caution in individuals with a seafood allergy.
  • Must be used under medical supervision.
Directions for Use
  • Check appearance before use and shake well.
  • Use at room temperature.
  • Handle aseptically to ensure product remains sterile.
  • Usage to be determined by a healthcare professional.
  • Do not dilute or add medications to the formula.
Storage
  • Store in a cool, dry place.
  • Once opened, close the bottle and store in a refrigerator.
  • Discard unused content after 24 hours.
Order Information

Contact Nutricia Customer Experience 0800 688 747

Nutrison  Product Code  Units per carton  Pharmacode 
1000ml OpTri Bottle 132202 8  2632969
Ingredients

Full ingredients list and nutritional information is available on the product fact sheet.

Allergen & Cultural Information
  • Contains: milk, soy and fish.
  • Halal certified.
  • Nutricia UK and/or Ireland have Kosher approval for this product.
  • No gluten containing ingredients. No detectable gluten when tested to a sensitivity level of less than 5 parts per million (<5 ppm i.e. <5mg/kg).
  • Low lactose (lactose <2g/100g).
References
  1. World Health Organization. Protein and amino acid requirements in human nutrition: report of a joint FAO/WHO/UNU expert consultation. 2007; WHO technical report series ; no. 935.
  2. Kuyumcu S, Menne D, Curcic J, et al. Noncoagulating enteral formula can empty faster from the stomach: A double-blind, randomized crossover trial using magnetic resonance imaging. Journal of Parenteral and Enteral Nutrition. 2015;39:544-551.
  3. van den Braak CC, Klebach M, Abrahamse E, et al. A novel protein mixture containing vegetable proteins renders enteral nutrition products noncoagulating after in vitro gastric digestion. Clinical Nutrition. 2013;32:765- 771.
  4. Klebach M, Hofman Z, Bluemel S, et al. Effect of protein type in enteral nutrition formulas on coagulation in the stomach in vivo: Post hoc analyses of a randomized controlled trial with MRI. Abstract presented at Clinical Nutrition Week, January 16–19; Austin, Tx. Journal of Parenteral and Enteral Nutrition. 2016;40:134(21).
  5. Luttikhold J, van Norren K, Rijna H, et al. Jejunal feeding is followed by a greater rise in plasma cholecystokinin, peptide YY, glucagon-like peptide 1, and glucagon-like peptide 2 concentrations compared with gastric feeding in vivo in humans: a randomized trial. Am J Clin Nutr. 2016;103:435–43.
  6. Abrahamse E, van der Lee S, van den Braak S, et al. Gastric non coagulation of enteral tube feed yields faster gastric emptying of protein in a dynamic in vitro model. Abstract presented at 34th ESPEN Congress. Sept 8-11; Barcelona, Spain. Clinical Nutrition Supplements. 2012;7:PP239(119).
  7. Liu J, Klebach M, Abrahamse E, et al. Specific protein mixture reduces coagulation: An in vitro stomach model study mimicking a gastric condition in critically ill patients. Poster presented at 38th ESPEN Congress. 17-20 September; Copenhagen, Denmark. Clinical Nutrition. 2016;35:MON-P182 (S220).
  8. Beckers EJ, Jeukendrup AE et al.  Gastric empty of carbohydrate–medium chain triglyceride suspensions at rest. Int J Sports Med. 1992 Nov;13(8):581-4.
  9. Hunt JN, Knox MT. A relation between the chain length of fatty acids and the slowing of gastric emptying.  J Physiol.1968 Feb;194(2):327-36.
  10. Cooper DA, Eldridge AL, Peters JC.  Dietary carotenoids and certain cancer, heart disease and age-related macular degeneration: A review of recent research.  Nutrition Reviews 1999; 57:201-214.
Additional Information

^ In accordance with Australia New Zealand Food Standards Code – Standard 2.9.5